Dr. Carlos Trujillo Botero is a medical doctor specializing in Genetics and Reproductive Genetics, with over thirty years of experience in clinical and medical genetics. He is both an accomplished researcher and educator.
He studied at Boston University and Boston City Hospital under the supervision of Dr. Aubrey Milunsky, Dr. Mary Louise Buysee, and Dr. Murray Finegold. He completed postgraduate studies at the University of Wisconsin and Mount Sinai Hospital in Milwaukee, USA. He received training in Chorionic Villus Sampling at the Reproductive Institute of Chicago with Dr. Yuri Verlinsky, and in Preimplantation Genetics, also at Guy's Hospital with Dr. Caroline Ogilve, and at St. Thomas' Hospital with Dr. Alan Handyside in London, UK.
After completing his specialization, he worked in Colombia and established the first program for prenatal diagnosis, genetic amniocentesis, chorionic villus sampling, cordocentesis, and biochemical screening. He then worked abroad for many years, particularly in the Middle East, where he established the first preimplantation genetics program at Erfan Hospital in Jeddah (Saudi Arabia) and at the King Fahd Research Center, also in Jeddah. He has been associated with the Inser Group since 2023.
Biography
Dr. Carlos Trujillo Botero is a medical doctor specializing in Genetics and Reproductive Genetics, with over thirty years of experience in clinical and medical genetics. He is both an accomplished researcher and educator.
He studied at Boston University and Boston City Hospital under the supervision of Dr. Aubrey Milunsky, Dr. Mary Louise Buysee, and Dr. Murray Finegold. He completed postgraduate studies at the University of Wisconsin and Mount Sinai Hospital in Milwaukee, USA. He received training in Chorionic Villus Sampling at the Reproductive Institute of Chicago with Dr. Yuri Verlinsky, and in Preimplantation Genetics, also at Guy's Hospital with Dr. Caroline Ogilve, and at St. Thomas' Hospital with Dr. Alan Handyside in London, UK.
After completing his specialization, he worked in Colombia and established the first program for prenatal diagnosis, genetic amniocentesis, chorionic villus sampling, cordocentesis, and biochemical screening. He then worked abroad for many years, particularly in the Middle East, where he established the first preimplantation genetics program at Erfan Hospital in Jeddah (Saudi Arabia) and at the King Fahd Research Center, also in Jeddah. He has been associated with the Inser Group since 2023.